GlassScriptPhysician profile
Jill R Crosson
NPI 1992936249
$3,637.46
in general payments reported to CMS, 2019-2025
20 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $501 · 2021: $226 · 2022: $811 · 2023: $229 · 2024: $1,109 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878 · Travel and Lodging: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.93 |
| Travel and Lodging | $674.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novus Surgical Solutions LLC | $923.73 | 2020-2022 | |
| Novus Surgical Consultants | $724.97 | 2022-2024 | |
| Depuy Synthes Sales INC. | $458.59 | 2019-2025 | Orthovisc, Monovisc |
| Ferring Pharmaceuticals INC. | $452.95 | 2019-2025 | Euflexxa |
| Arthrex, INC. | $282.65 | 2024 | |
| Bioventus LLC | $183.85 | 2019-2023 | Exogen Ultrasound Bone Healing System, Gelsyn-3, Durolane |
| Electronic Waveform Lab, INC. | $154.21 | 2019-2025 | |
| Arteriocyte Medical Systems, INC. | $107.36 | 2021-2022 | |
| Ermi LLC | $88.12 | 2019-2024 | |
| Radius Health, INC. | $64.84 | 2019-2023 | Tymlos |
| Vertex Pharmaceuticals Incorporated | $32.44 | 2025 | |
| Smith+Nephew, INC. | $27.46 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $25.79 | 2023 | Iovera, Zilretta, Exparel |
| Fidia Pharma USA INC. | $20.50 | 2020 | |
| Horizon Therapeutics Plc | $19.84 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $19.32 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.28 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.16 | 2022 | |
| Zimmer Biomet Holdings, INC. | $11.92 | 2019 | |
| Synergy Orthopedics, LLC | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Crosson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.